Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project (2025)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1002/art.43038
- Subjects: DOENÇAS REUMÁTICAS; DOENÇAS AUTOIMUNES; SINAIS E SINTOMAS
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Arthritis & rheumatology
- ISSN: 2326-5191
- Volume/Número/Paginação/Ano: v. 77, n. 4, p. 477-489, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
FAGHIHI-KASHANI, Sara et al. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project. Arthritis & rheumatology, v. 77, n. 4, p. 477-489, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/84762. Acesso em: 13 fev. 2026. -
APA
Faghihi-Kashani, S., Yoshida, A., Bozan, F., Zanframundo, G., Rozza, D., Loganathan, A., et al. (2025). Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project. Arthritis & rheumatology, 77( 4), 477-489. doi:10.1002/art.43038 -
NLM
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, Shinjo SK. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project [Internet]. Arthritis & rheumatology. 2025 ; 77( 4): 477-489.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84762 -
Vancouver
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, Dourado E, Sambataro G, Bauer-Ventura I, Shinjo SK. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for anti-synthetase syndrome project [Internet]. Arthritis & rheumatology. 2025 ; 77( 4): 477-489.[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/84762 - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre o DOI: 10.1002/art.43038 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
